导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.13% | 480/683 |
| 近一周 | -0.05% | 618/789 |
| 近一月 | -0.80% | 706/781 |
| 近一季 | -0.10% | 684/764 |
| 近半年 | -0.07% | 629/732 |
| 近一年 | 1.30% | 487/681 |
| 近两年 | 8.40% | 198/574 |
| 近三年 | 18.29% | 35/523 |
| 成立以来 | 39.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.08% 497/755 |
1.37% 206/838 |
-0.22% 605/871 |
- - |
| 2024 | 6.41% 108/819 |
2.43% 66/3226 |
2.13% 95/3360 |
-0.13% 647/800 |
1.85% 431/819 |
| 2023 | 9.56% 25/3108 |
3.12% 37/2776 |
2.11% 41/2849 |
1.82% 27/2940 |
2.18% 43/3108 |
| 2022 | 2.99% 409/2727 |
1.15% 51/1949 |
1.52% 168/2522 |
1.59% 175/2598 |
-1.28% 2295/2732 |
| 2021 | 6.16% 188/2409 |
1.13% 252/2068 |
1.76% 138/2668 |
1.59% 431/2731 |
1.54% 271/2416 |
| 2020 | 3.58% 289/2196 |
1.81% 980/1576 |
0.42% 152/2274 |
0.49% 417/2475 |
0.83% 1429/2563 |
| 2019 | 3.64% 891/1720 |
1.13% 407/603 |
0.17% 524/635 |
1.19% 718/1762 |
1.10% 686/1956 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 国联聚业定期开放债券 VS. () |